• Media type: E-Article
  • Title: Phase II study of the MEK inhibitor refametinib (BAY 86-9766) in combination with gemcitabine in patients with unresectable, locally advanced, or metastatic pancreatic cancer: Biomarker results
  • Contributor: Riess, Hanno; Van Laethem, Jean-Luc; Martens, Uwe Marc; Heinemann, Volker; Michl, Patrick; Peeters, Marc; Van Brummelen, David; Weekes, Colin D.; Dueland, Svein; Schmiegel, Wolff H.; Giurescu, Marius; Garosi, Vittorio Luigi; Schulz, Anke; Seidel, Henrik; Childs, Barrett H.; Teufel, Michael
  • Published: American Society of Clinical Oncology (ASCO), 2014
  • Published in: Journal of Clinical Oncology, 32 (2014) 15_suppl, Seite 4129-4129
  • Language: English
  • DOI: 10.1200/jco.2014.32.15_suppl.4129
  • ISSN: 0732-183X; 1527-7755
  • Keywords: Cancer Research ; Oncology
  • Origination:
  • Footnote:
  • Access State: Open Access